Staphylococcus pettenkoferi : an underrecognized species with clinically relevant antimicrobial resistance. A comprehensive genomic European study
Abstract
Staphylococcus pettenkoferi has increasingly been reported as a human pathogen, with virulence potential recently confirmed in vivo. However, its genomic diversity and antimicrobial resistance remain insufficiently characterized. This study, conducted within the PETTENK-OS project of the ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS), aimed to characterize the genomic diversity and resistome of this underrecognized coagulase-negative staphylococcus (CoNS). Whole-genome sequencing was performed on 61 European clinical isolates (mainly bloodstream infections and osteomyelitis) from 17 hospitals in five countries, plus two reference strains. Antimicrobial susceptibility profiles were determined by disk diffusion and broth microdilution (2025 EUCAST breakpoints). Phylogenetic analyses clustered the 63 isolates into two major clades: Clade I (n = 51; subclades I-A, n = 47, and I-B, n = 4) and Clade II (subclades II-A, n = 8, and II-B, n = 3). Susceptibility rates were below 70% for cefoxitin, erythromycin, and levofloxacin, whereas high susceptibility (>90%) was observed for vancomycin, teicoplanin, dalbavancin, aminoglycosides, oxazolidinones, trimethoprim-sulfamethoxazole, fusidic acid, and tetracycline. Nearly all isolates (92.1%) were fosfomycin-resistant. Daptomycin MIC50/90 values (1/2 mg/L) were elevated, including eight resistant isolates carrying mutations in walKR, cls1, and/or cls2 genes. Twenty-two isolates (35.4%) were multidrug-resistant, and 18 (28.6%) were methicillin-resistant, all in subclade I-A and mecA-positive within SCCmec type IV. This study provides a comprehensive genomic and phenotypic assessment of antimicrobial resistance in S. pettenkoferi, revealing widespread multidrug-resistant lineages, including ceftobiprole- and daptomycin-resistant isolates across distinct clades. These findings underscore the need for continued surveillance and improved diagnostics for this increasingly encountered CoNS species.
Related
- Staphylococcus aureus in Bovine Mastitis: Pathogenesis, Antimicrobial Resistance, and Emerging Control Strategies
- Sequence-Activity Relationships and Integrated In Silico and In Vitro Mechanistic Study of the Antimicrobial Peptide PEP-4 against Staphylococcus aureus
- Machine learning–driven prediction of antimicrobial resistance in Staphylococcus aureus using genomic and allelic signatures
- Staphylococcus aureus in bovine mastitis in northwestern Iran: patterns of antimicrobial and multidrug resistance, biofilm formation, and virulence/resistance gene carriage
- Methicillin resistance and antimicrobial non-susceptibility trends among Staphylococcus aureus clinical isolates in Aseer, Saudi Arabia (2013–2024): A retrospective laboratory-based surveillance study
BibTeX
@article{magnan2026staphylococcus,
title = {{Staphylococcus pettenkoferi : an underrecognized species with clinically relevant antimicrobial resistance. A comprehensive genomic European study}},
author = {Chloé Magnan and Matthieu Curtil-Dit-Galin and Madjid Morsli and Vincent Cattoir and Caroline Piau-Couapel and Bo Söderquist and Barbara Kahl and Olivier Denis and Kenza Rwayane and Stéphane Corvec and Patrice François and Florian Salipante and Alix Pantel and Catherine Dunyach-Remy and Frédéric Laurent and Jean-Philippe Lavigne},
journal = {Emerging microbes \& infections},
year = {2026},
month = sep,
doi = {10.1080/22221751.2026.2724635},
url = {https://inserm.hal.science/inserm-05753431v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Staphylococcus pettenkoferi : an underrecognized species with clinically relevant antimicrobial resistance. A comprehensive genomic European study
AU - Chloé Magnan
AU - Matthieu Curtil-Dit-Galin
AU - Madjid Morsli
AU - Vincent Cattoir
AU - Caroline Piau-Couapel
AU - Bo Söderquist
AU - Barbara Kahl
AU - Olivier Denis
AU - Kenza Rwayane
AU - Stéphane Corvec
AU - Patrice François
AU - Florian Salipante
AU - Alix Pantel
AU - Catherine Dunyach-Remy
AU - Frédéric Laurent
AU - Jean-Philippe Lavigne
PY - 2026
DA - 2026/09/16
JO - Emerging microbes & infections
DO - 10.1080/22221751.2026.2724635
UR - https://inserm.hal.science/inserm-05753431v1
AB - Staphylococcus pettenkoferi has increasingly been reported as a human pathogen, with virulence potential recently confirmed in vivo. However, its genomic diversity and antimicrobial resistance remain insufficiently characterized. This study, conducted within the PETTENK-OS project of the ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS), aimed to characterize the genomic diversity and resistome of this underrecognized coagulase-negative staphylococcus (CoNS). Whole-genome sequencing was performed on 61 European clinical isolates (mainly bloodstream infections and osteomyelitis) from 17 hospitals in five countries, plus two reference strains. Antimicrobial susceptibility profiles were determined by disk diffusion and broth microdilution (2025 EUCAST breakpoints). Phylogenetic analyses clustered the 63 isolates into two major clades: Clade I (n = 51; subclades I-A, n = 47, and I-B, n = 4) and Clade II (subclades II-A, n = 8, and II-B, n = 3). Susceptibility rates were below 70% for cefoxitin, erythromycin, and levofloxacin, whereas high susceptibility (>90%) was observed for vancomycin, teicoplanin, dalbavancin, aminoglycosides, oxazolidinones, trimethoprim-sulfamethoxazole, fusidic acid, and tetracycline. Nearly all isolates (92.1%) were fosfomycin-resistant. Daptomycin MIC50/90 values (1/2 mg/L) were elevated, including eight resistant isolates carrying mutations in walKR, cls1, and/or cls2 genes. Twenty-two isolates (35.4%) were multidrug-resistant, and 18 (28.6%) were methicillin-resistant, all in subclade I-A and mecA-positive within SCCmec type IV. This study provides a comprehensive genomic and phenotypic assessment of antimicrobial resistance in S. pettenkoferi, revealing widespread multidrug-resistant lineages, including ceftobiprole- and daptomycin-resistant isolates across distinct clades. These findings underscore the need for continued surveillance and improved diagnostics for this increasingly encountered CoNS species.
SN - 2222-1751
SN - 2222-1751
ER -